USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus

mBio

Volumn 6, Issue 2, 2015, Pages

  Boyle Vavra, Susan ^a   Li, Xue ^b,g   Alam, Md Tauqeer ^c   Read, Timothy D ^c   Sieth, Julia ^a   Cywes Bentley, Colette ^b   Dobbins, Ginette ^e   David, Michael Z ^a   Kumar, Neha ^a   Eells, Samantha J ^d   Miller, Loren G ^d   Boxrud, David J ^e   Chambers, Henry F ^f   Lynfield, Ruth ^e   Lee, Jean C ^b   Daum, Robert S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MINNESOTA DEPARTMENT OF HEALTH   (United States)

^f SAN FRANCISCO GENERAL HOSPITAL   (United States)

^g INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; CAP5 PROTEIN, STAPHYLOCOCCUS; VIRULENCE FACTOR;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CAP5 GENE; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; GENE AMPLIFICATION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC COMPLEMENTATION; GENETIC CONSERVATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE; UNITED STATES; BACTERIAL CAPSULE; BACTERIAL GENOME; CONSERVED SEQUENCE; DNA SEQUENCE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MUTATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

BACTERIAL CAPSULES; BACTERIAL PROTEINS; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; GENETIC COMPLEMENTATION TEST; GENOME, BACTERIAL; HUMANS; MUTATION; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84928796787     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02585-14     Document Type: Article

References (54)

1. Daum RS, Spellberg B. 2012. Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis 54:560–567. http://dx.doi.org/10.1093/cid/cir828.
2. O’Riordan K, Lee JC. 2004. Staphylococcus aureus capsular polysaccha-rides. Clin Microbiol Rev 17:218–234. http://dx.doi.org/10.1128/CMR.17.1.218-234.2004.
3. Trotter CL, McVernon J, Ramsay ME, Whitney CG, Mulholland EK, Goldblatt D, Hombach J, Kieny M-P, SAGE Subgroup. 2008. Optimising the useofconjugate vaccinestoprevent disease caused byHaemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 26:4434–4445. http://dx.doi.org/10.1016/j.vaccine.2008.05.073.
4. Hochkeppel HK, Braun DG, Vischer W, Imm A, Sutter S, Staeubli U, Guggenheim R, Kaplan EL, Boutonnier A, Fournier JM. 1987. Serotyp-ing and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodiestocapsular polysaccharide types 5and 8. J Clin Microbiol 25:526–530.
5. Arbeit RD, Karakawa WW, Vann WF, Robbins JB. 1984. Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis 2:85–91. http://dx.doi.org/10.1016/0732-8893(84)90002-6.
6. Karakawa WW, Vann WF. 1982. Capsular polysaccharides of Staphylo-coccus aureus. Semin Infect Dis 4:285–293.
7. Sompolinsky D, Samra Z, Karakawa WW, Vann WF, Schneerson R, Malik Z. 1985. Encapsulation and capsular types in isolates of Staphylo-coccus aureusfrom different sources and relationshiptophage types.J Clin Microbiol 22:828–834.
8. Lee JC, Liu MJ, Parsonnet J, Arbeit RD. 1990. Expression of type-8 capsular polysaccharide and production of toxic shock syndrome toxin-1 are associated among vaginal isolates of Staphylococcus aureus. J Clin Mi-crobiol 28:2612–2615.
9. Roghmann M, Taylor KL, Gupte A, Zhan M, Johnson JA, Cross A, Edelman R, Fattom AI. 2005. Epidemiology of capsular and surface poly-saccharide in Staphylococcus aureus infections complicated by bacterae-mia.JHosp Infect 59:27–32. http://dx.doi.org/10.1016/j.jhin.2004.07.014.
10. Nanra JS, Buitrago SM, Crawford S, Ng J, Fink PS, Hawkins J, Scully IL, McNeil LK, Aste-Amézaga JM, Cooper D, Jansen KU, Anderson AS. 2013. Capsular polysaccharides are an important immune evasion mech anism for Staphylococcus aureus. Hum Vaccin Immunother 9:480–487. http://dx.doi.org/10.4161/hv.23223.
11. Thakker M, Park JS, Carey V, Lee JC. 1998. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulencein a murine bacteremia model. Infect Immun 66:5183–5189.
12. Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R. 2002. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 346: 491–496. http://dx.doi.org/10.1056/NEJMoa011297.
13. Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D. 2014. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: phase III randomized study. Hum Vac-cin Immunother e34414. http://dx.doi.org/10.4161/hv.34414.
14. Bagnoli F, Bertholet S, Grandi G. 2012. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front Cell Infect Micro-biol 2:16. http://dx.doi.org/10.3389/fcimb.2012.00016.
15. Diekema DJ, Richter SS, Heilmann KP, Dohrn CL, Riahi F, Tendolkar S, McDanel JS, Doern GV. 2014. Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study. Infect Control Hosp Epidemiol 35: 285–292. http://dx.doi.org/10.1086/675283.
16. Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, Albrecht V, Moran GJ, EMERGEncy ID Net Study Group. 2011. Comparison ofStaphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis 53: 144–149. http://dx.doi.org/10.1093/cid/cir308.
17. Ma XX, Ito T, Tiensasitorn C, Jamklang M, Chongtrakool P, Boyle-Vavra S, Daum RS, Hiramatsu K. 2002. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 46: 1147–1152. http://dx.doi.org/10.1128/AAC.46.4.1147-1152.2002.
18. Boyle-Vavra S, Daum RS. 2007. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 87:3–9. http://dx.doi.org/10.1038/labinvest.3700501.
19. Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, des Etages SA, Jones A, Palazzolo-Ballance AM, Perdreau-Remington F, Sensabaugh GF, DeLeo FR, Chambers HF. 2008. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 197:1523–1530. http://dx.doi.org/10.1086/587907.
20. Thurlow LR, Joshi GS, Clark JR, Spontak JS, Neely CJ, Maile R, Richardson AR. 2013. Functional modularity of the arginine catabolic mobile element contributes to the successofUSA300 methicillin-resistant Staphylococcus aureus. Cell Host Microbe 13:100–107. http://dx.doi.org/10.1016/j.chom.2012.11.012.
21. Planet PJ, LaRussa SJ, Dana A, Smith H, Xu A, Ryan C, Uhlemann AC, Boundy S, Goldberg J, Narechania A, Kulkarni R, Ratner AJ, Geoghe-gan JA, Kolokotronis SO, Prince A. 2013. Emergence of the epidemic methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speG-mediated adaptations for survival on skin. mBio 4(6):e00889-13. http://dx.doi.org/10.1128/mBio.00889-13.
22. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J, Daum RS. 2008. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 198:561–570. http://dx.doi.org/10.1086/590157.
23. Sutter DE, Summers AM, Keys CE, Taylor KL, Frasch CE, Braun LE, Fattom AI, Bash MC. 2011. Capsular serotype of Staphylococcus aureus in the era of community-acquired MRSA. FEMS Immunol Med Microbiol 63:16–24. http://dx.doi.org/10.1111/j.1574-695X.2011.00822.x.
24. Anderson AS, Miller AA, Donald RG, Scully IL, Nanra JS, Cooper D, Jansen KU. 2012. Development of a multicomponent Staphylococcus au-reus vaccine designed to counter multiple bacterial virulence factors. Hum Vaccin Immunother 8:1585–1594. http://dx.doi.org/10.4161/hv.21872.
25. Levy J, Licini L, Haelterman E, Moris P, Lestrate PR, Damaso S, Boutriau D. 2014. Evaluation of an investigational 4-component Staphy-lococcus aureus vaccine with or without ASO3B adjuvant in healthy adults: results from a phase I trial, abstr 145. Int Symp Staphylococci Staphylo-coccal Infect, Chicago, IL.
26. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y, Otto M. 2009. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 106:5883–5888. http://dx.doi.org/10.1073/pnas.0900743106.
27. Cocchiaro JL, Gomez MI, Risley A, Solinga R, Sordelli DO, Lee JC. 2006. Molecular characterization of the capsule locus from non-typeable Staphylococcus aureus. Mol Microbiol 59:948–960. http://dx.doi.org/10.1111/j.1365-2958.2005.04978.x.
28. Timofeyeva Y, Scully IL, Anderson AS. 2014. Immunofluorescence microscopy for the detection of surface antigens in methicillin-resistant Staphylococcus aureus (MRSA). Methods Mol Biol 1085:85–95. http://dx.doi.org/10.1007/978-1-62703-664-1_4.
29. Wacker M, Wang L, Kowarik M, Dowd M, Lipowsky G, Faridmoayer A, Shields K, Park S, Alaimo C, Kelley KA, Braun M, Quebatte J, Gam-billara V, Carranza P, Steffen M, Lee JC. 2014. Prevention of Staphylo-coccus aureus infections by glycoprotein vaccines synthesized in Esche-richia coli. J Infect Dis 209:1551–1561. http://dx.doi.org/10.1093/infdis/jit800.
30. Benson MA, Ohneck EA, Ryan C, Alonzo F, III, Smith H, Narechania A, Kolokotronis SO, Satola SW, Uhlemann AC, Sebra R, Deikus G, Shopsin B, Planet PJ, Torres VJ. 2014. Evolution of hypervirulence by a MRSA clone through acquisition of a transposable element. Mol Micro-biol 93:664–681. http://dx.doi.org/10.1111/mmi.12682.
31. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. 2006. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 193:1495–1503. http://dx.doi.org/10.1086/503777.
32. Ouyang S, Sau S, Lee CY. 1999. Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus. J Bacteriol 181:2492–2500.
33. Alam MT, Read TD, Petit RA, III, Boyle-Vavra S, Miller LG, Eells SJ, Daum RS, David MZ. 2015. Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing. mBio 6(2):e00054-15.
34. Li W, Ulm H, Rausch M, Li X, O’Riordan K, Lee JC, Schneider T, Müller CE. 2014. Analysis of the Staphylococcus aureus capsule biosynthesis pathwayinvitro: characterizationofthe UDP-GlcNAcC6dehydratases CapD and CapE and identification of enzyme inhibitors. Int J Med Mi-crobiol 304:958–969. http://dx.doi.org/10.1016/j.ijmm.2014.06.002.
35. Wann ER, Dassy B, Fournier JM, Foster TJ. 1999. Genetic analysis of the cap5 locus of Staphylococcus aureus. FEMS Microbiol Lett 170:97–103. http://dx.doi.org/10.1111/j.1574-6968.1999.tb13360.x.
36. Kneidinger B, O’Riordan K, Li J, Brisson JR, Lee JC, Lam JS. 2003. Three highly conserved proteins catalyze the conversion of UDP-N-acetyl-D-glucosamine to precursors for the biosynthesis of O antigen in Pseudomonas aeruginosa O11 and capsule in Staphylococcus aureus type 5. Implications for the UDP-N-acetyl-L-fucosamine biosynthetic pathway. J Biol Chem 278:3615–3627. http://dx.doi.org/10.1074/jbc.M203867200.
37. Miyafusa T, Caaveiro JM, Tanaka Y, Tanner ME, Tsumoto K. 2013. Crystal structureofthe capsular polysaccharide synthesizing protein CapE of Staphylococcus aureus. Biosci Rep 33:e0043. http://dx.doi.org/10.1042/BSR20130017.
38. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. 2000. Multi-locus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38:1008–1015.
39. David MZ, Taylor A, Lynfield R, Boxrud DJ, Short G, Zychowski D, Boyle-Vavra S, Daum RS. 2013. Comparing pulsed-field gel electropho-resis with multilocus sequence typing, spa typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for Panton-Valentine leu-kocidin, arcA, and opp3 in methicillin-resistant Staphylococcus aureus isolates at a U.S. medical center. J Clin Microbiol 51:814–819. http://dx.doi.org/10.1128/JCM.02429-12.
40. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). 2009. Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 53: 4961–4967. http://dx.doi.org/10.1128/AAC.00579-09.
41. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132. http://dx.doi.org/10.1086/313461.
42. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41:5113–5120. http://dx.doi.org/10.1128/JCM.41.11.5113-5120.2003.
43. Lee JC, Liu MJ, Parsonnet J, Arbeit RD. 1990. Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus. J Clin Mi-crobiol 28:2612–2615.
44. Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, Zychowski D, Kumar N, Cruz D, Boyle-Vavra S, Daum RS. 2012. Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin Infect Dis 54: 1523–1535. http://dx.doi.org/10.1093/cid/cis213.
45. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. 2009. Jalview version 2—a multiple sequence alignment editor and analysis workbench. Bioinformatics 25:1189–1191. http://dx.doi.org/10.1093/bioinformatics/btp033.
46. Tewhey R, Cannavino CR, Leake JA, Bansal V, Topol EJ, Torkamani A, Bradley JS, Schork NJ. 2012. Genetic structure of community acquired methicillin-resistant Staphylococcus aureus USA300. BMC Genomics 13: 508. http://dx.doi.org/10.1186/1471-2164-13-508.
47. Uhlemann A-, Dordel J, Knox JR, Raven KE, Parkhill J, Holden MTG, Peacock SJ, Lowy FD. 2014. Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci U S A 111:6738–6743. http://dx.doi.org/10.1073/pnas.1401006111.
48. Highlander SK, Hultén KG, Qin X, Jiang H, Yerrapragada S, Mason EO, Jr, Shang Y, Williams TM, Fortunov RM, Liu Y, Igboeli O, Petrosino J, Tirumalai M, Uzman A, Fox GE, Cardenas AM, Muzny DM, Hemphill L, Ding Y, Dugan S, Blyth PR, Buhay CJ, Dinh HH, Hawes AC, Holder M, Kovar CL, Lee SL, Liu W, Nazareth LV, Wang Q, Zhou J, Kaplan SL, Weinstock GM. 2007. Subtle genetic changes enhance virulenceof methicillin resistant and sensitiveStaphylococcus aureus. BMC Microbiol 7:99. http://dx.doi.org/10.1186/1471-2180-7-99.
49. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731–739. http://dx.doi.org/10.1016/S0140-6736(06)68231-7.
50. Sabirova JS, Xavier BB, Hernalsteens JP, De Greve H, Ieven M, Goos-sens H, Malhotra-Kumar S. 2014. Complete genome sequences of two prolific biofilm-forming Staphylococcus aureus isolates belonging to USA300 and EMRSA-15 clonal lineages. Genome Announc 2:e00610-14. http://dx.doi.org/10.1128/genomeA.00610-14.
51. Altman DR, Sebra R, Hand J, Attie O, Deikus G, Carpini KW, Patel G, Rana M, Arvelakis A, Grewal P, Dutta J, Rose H, Shopsin B, Daefler S, Schadt E, Kasarskis A, van Bakel H, Bashir A, Huprikar S. 2014. Transmission of methicillin-resistant Staphylococcus aureus via deceased donor liver transplantation confirmed by whole genome sequencing. Am J Transplant 14:2640–2644. http://dx.doi.org/10.1111/ajt.12897.
52. Alam MT, Petit RA, III, Crispell EK, Thornton TA, Conneely KN, Jiang Y, Satola SW, Read TD. 2014. Dissecting vancomycin-intermediate resistance in Staphylococcus aureususing genome-wide association. Genome Biol Evol 6:1174–1185. http://dx.doi.org/10.1093/gbe/evu092.
53. Bertels F, Silander OK, Pachkov M, Rainey PB, van Nimwegen E. 2014. Automated reconstruction of whole-genome phylogenies from short-sequence reads. Mol Biol Evol 31:1077–1088. http://dx.doi.org/10.1093/molbev/msu088.
54. Augustin J, Götz F. 1990. Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS Microbiol Lett 54:203–207. http://dx.doi.org/10.1016/0378-1097(90)90283-V.